Understanding Treatment Effect Timing

This segment focuses on interpreting the timing of treatment effects observed in progression-free survival curves. The discussion highlights that early outcomes appear similar between treatment arms, with separation occurring later in the follow-up period. This suggests that the benefit of the combination therapy may emerge over time rather than immediately. The speakers consider whether this pattern reflects underlying disease biology, where patients with more aggressive disease progress early regardless of treatment, while others derive longer-term benefit. The segment emphasizes the importance of examining the shape of Kaplan-Meier curves, not just median values, to understand treatment dynamics. This analysis provides insight into how different patient subgroups may respond to therapy and underscores the complexity of interpreting clinical trial results in RCC.